histamine has been researched along with Bladder Pain Syndrome in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interstitial cystitis/bladder pain syndrome (IC/BPS) is characterized by overexpression of monocyte chemoattractant protein-1 (MCP-1) in bladder tissues and induction of mast cell (MC) degranulation." | 5.38 | MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models. ( Bo, J; Huang, Y; Leng, J; Liu, D; Lv, J; Yang, G; Zhang, Y; Zhu, S, 2012) |
| "The topic of interstitial cystitis (IC), also known as painful bladder syndrome (PBS), and folate/one carbon metabolism has previously been unaddressed in research." | 2.61 | The potential role of folate metabolism in interstitial cystitis. ( Keagy, CD, 2019) |
| "Interstitial cystitis/bladder pain syndrome (IC/BPS) is characterized by overexpression of monocyte chemoattractant protein-1 (MCP-1) in bladder tissues and induction of mast cell (MC) degranulation." | 1.38 | MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models. ( Bo, J; Huang, Y; Leng, J; Liu, D; Lv, J; Yang, G; Zhang, Y; Zhu, S, 2012) |
| "A total of 40 women with interstitial cystitis and 29 healthy controls collected 24-hour urine samples." | 1.33 | Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. ( Kreder, KJ; Lamale, LM; Lutgendorf, SK; Zimmerman, MB, 2006) |
| "Many patients with interstitial cystitis (IC) also have irritable bowel syndrome (IBS), both of which occur overwhelmingly in women, are characterized by pain, and worsen under stress." | 1.29 | Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. ( Boucher, W; Pang, X; Sant, GR; Theoharides, TC; Triadafilopoulos, G, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Grundy, L | 1 |
| Caldwell, A | 1 |
| Garcia Caraballo, S | 1 |
| Erickson, A | 1 |
| Schober, G | 1 |
| Castro, J | 1 |
| Harrington, AM | 1 |
| Brierley, SM | 1 |
| Keagy, CD | 1 |
| Lv, J | 1 |
| Huang, Y | 1 |
| Zhu, S | 1 |
| Yang, G | 1 |
| Zhang, Y | 1 |
| Leng, J | 1 |
| Bo, J | 1 |
| Liu, D | 1 |
| Lamale, LM | 1 |
| Lutgendorf, SK | 1 |
| Zimmerman, MB | 1 |
| Kreder, KJ | 1 |
| Pang, X | 1 |
| Boucher, W | 1 |
| Triadafilopoulos, G | 1 |
| Sant, GR | 1 |
| Theoharides, TC | 1 |
| Bouchelouche, K | 1 |
| Horn, T | 1 |
| Nordling, J | 1 |
| Larsen, S | 1 |
| Hald, T | 1 |
| Bouchelouche, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acupuncture for Female Interstitial Cystitis/Painful Bladder Syndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial[NCT02232282] | 22 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| Mediators of Neurogenic Inflammation in the Urinary Tract as Key Factors in the Painful Bladder Syndrome / Interstitial Cystitis and Bladder Dysfunction[NCT00775281] | 45 participants (Anticipated) | Observational | 2006-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Change in worst pain as measured by the Brief Pain Inventory-Short Form. Scores range from 0 to 10 and higher scores indicate more pain. Change is calculated as the 6 weeks score minus the baseline score. (NCT02232282)
Timeframe: 0 weeks, 6 weeks
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Minimal Acupuncture | -2.08 |
| Standard Acupuncture Treatment | -2.91 |
The total number of adverse events experienced by women receiving acupuncture (NCT02232282)
Timeframe: 0 weeks, 12 weeks
| Intervention | total number of adverse events (Number) |
|---|---|
| Minimal Acupuncture | 0 |
| Standard Acupuncture Treatment | 0 |
The total number of acupuncture sessions stopped due to poor tolerability of acupuncture (NCT02232282)
Timeframe: 0 weeks, 6 weeks
| Intervention | total number of sessions (Number) |
|---|---|
| Minimal Acupuncture | 0 |
| Standard Acupuncture Treatment | 0 |
1 review available for histamine and Bladder Pain Syndrome
| Article | Year |
|---|---|
The potential role of folate metabolism in interstitial cystitis.
Topics: Cystitis, Interstitial; Endothelium; Female; Folic Acid; Histamine; Humans; Hypersensitivity; Mast C | 2019 |
5 other studies available for histamine and Bladder Pain Syndrome
| Article | Year |
|---|---|
Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H
Topics: Administration, Intravesical; Animals; Calcium Signaling; Cells, Cultured; Cystitis, Interstitial; F | 2020 |
MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models.
Topics: Animals; Cell Line; Chemokine CCL2; Cystitis, Interstitial; Female; Flow Cytometry; Histamine; Hista | 2012 |
Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis.
Topics: Adult; Aged; Biomarkers; Cystitis, Interstitial; Female; Histamine; Humans; Interleukin-6; Methylhis | 2006 |
Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis.
Topics: Chymases; Colon; Colonic Diseases, Functional; Cystitis, Interstitial; Female; Histamine; Humans; Ma | 1996 |
Calcium signaling in cultured human detrusor smooth muscle cells from patients with interstitial cystitis.
Topics: Calcium; Cell Division; Cystitis, Interstitial; Female; Histamine; Humans; Leukotriene D4; Muscle, S | 2001 |